BeStock  
Stocks › Biotechnology › ARGX

argenx SE ARGX

US equityMarket cap rank #379Biotechnology
$927.21 +$32.44 (+3.63%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $935.99 +0.95%
Open$894.78
Prev close$894.77
Day range$892.36 – $929.88
Volume379.3K
Market cap$58.31B
P/E (TTM)32.1
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings30.9x
CheapRich

Above its usual level · 67th percentile, 5-year average -73.3x

#2140 of 2972 stocks by PE (1 = cheapest)

Price / book6.7x
CheapRich

Below its usual level · 31st percentile, 5-year average 7.3x

#4633 of 5311 stocks by PB (1 = cheapest)

Price / sales9.6x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 34.2x

#4433 of 5150 stocks by PS (1 = cheapest)

P/E over five years

-931x-553x-176x202xSep '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$900.00
Price vs. fair value+3.0%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 6.67 – 7.31 31% (cheaper than usual) #4633 of 5311 (1 = cheapest)
PE 30.93 27.51 -73.31 67% (pricier than usual) #2140 of 2972 (1 = cheapest)
PS 9.65 7.56 34.25 0% (cheaper than usual) #4433 of 5150 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$900.00
Economic moatNone
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on ARGX.

Sign in to join the discussion.

Scroll to Top